Workflow
温氏股份(300498) - 2025年11月28日投资者关系活动记录表
2025-12-01 07:06
编号:202514 | 投资者关 | 现场调研 电话会议 | | --- | --- | | 系活动类 | 业绩说明会 路演活动 | | 别 | 券商策略会 其他活动 | | 参与单位 | 2025 年 11 月 28 日,公司前往广西南宁参加国海证券"桂启新程"2026 资本市场年会(线 | | 名称及人 | 下),国寿资管、交银施罗德基金、中金资管等 家机构共 位机构投资者参与。部 9 12 | | 员姓名 | 分名单详见附件清单。 | | | 重要提示:参会人员名单由组织机构提供并经整理后披露。公司无法保证所有参会人员 | | | 及其单位名称的完整性和准确性,敬请投资者注意。 | | 时间 | 年 月 日 2025 11 28 | | 地点 | 广西南宁 | | 上市公司 | 证券事务代表覃刚禄,投资者关系管理室主任史志茹 | | 接待人员 | | | 姓名 | | | | 一、Q&A | | | (一)养猪业务 | | | 1.请问公司当前疫病防控情况如何? | | 投资者关 | 答:近年来,公司构建了科学完善的生物安全防控体系,配备有空气过滤等硬件设 | | 系活动主 | 施,猪场实施 ...
唯特偶(301319) - 301319唯特偶投资者关系管理信息20251201
2025-12-01 02:26
Group 1: Overseas Business Expansion - The company has established subsidiaries in 6 locations, including the USA, Vietnam, and Thailand, with a significant increase in overseas revenue share in 2024 [2] - The Mexican factory enhances delivery capabilities and local operations are showing initial success [2] - Future plans include deepening overseas expansion as domestic capacity constraints are alleviated [2] Group 2: New Business Development - The company is focusing on major downstream clients and has successfully transitioned to a dual product matrix of "electronic assembly materials + reliability materials" [2] - Increased investments in overseas markets aim to enhance local production and delivery capabilities [2] - A complete international sales system is being established to support long-term growth [2] Group 3: Shareholder Actions - The controlling shareholder's planned reduction of holdings is the first since the company went public, driven by personal funding needs [2] - The company reported a 24% year-on-year revenue growth and a 15.98% increase in net profit for Q3 [2] Group 4: Domestic Substitution Progress - Domestic substitution is becoming essential for industrial upgrades, with increasing acceptance of domestic materials by downstream clients [3] - The company has achieved performance levels of core products that meet international standards, facilitating the replacement of foreign products [3] Group 5: Core Technology Barriers - The company has broken through technical barriers in several fields, including ultra-fine welding materials and low-temperature high-reliability welding materials [4] - A comprehensive product matrix has been established, focusing on reliability materials to provide modular solutions for global clients [4] Group 6: Profit Margin Improvement Plans - The company aims to optimize customer and order structures while systematically reducing costs to enhance overall operational efficiency and profitability [5] - Strategies include optimizing business processes and improving management capabilities to lower operational costs [6] Group 7: Operational Strategies - The company is addressing cost control challenges through process optimization and effective management of funds and expenses [6] - Focus on strategic emerging sectors, product premiumization, cost refinement, and digital operations to ensure sustainable growth [6]
和顺科技(301237) - 301237和顺科技投资者关系管理信息20251201
2025-12-01 01:16
杭州和顺科技股份有限公司 证券代码:301237 证券简称:和顺科技 投资者关系活动记录表 | | 亿"重点项目政策倾斜及杭州钱塘新区优质营商环境支持,各环节无缝衔 | | --- | --- | | | 接推动项目高效落地。 | | | 2、公司的竞争对手有哪些? | | | 答:公司始终对标全球新材料行业标杆日本东丽,无论是深耕多年的 | | | 薄膜业务,还是战略布局的碳纤维赛道,均以技术引领为核心导向,持续 | | | 攻坚高端领域,致力于成为新材料行业技术引领者。 | | 附件清单(如 | 无 | | 有) | | | 日期 | 2025年11月29日 | 编号:2025-016 | | 特定对象调研 分析师会议 ☐ | | | --- | --- | --- | | ☐ | 媒体采访 ☐业绩说明会 | | | 投资者关系 ☐ | 新闻发布会 路演活动 ☐ | | | 活动类别 ☐ | 现场参观 | | | | ☐其他(请文字说明其他活动内容) | | | 参与单位名 称及人员姓 | 财通证券 沈志滨、葆光资管 任为民、投资人 严 | 詹文俊、九纬私募基金 | | | 小平、陈勇勇 | | | 名 ...
长安汽车(000625) - 2025年11月30日投资者关系活动记录表
2025-12-01 01:14
Group 1: Company Overview and Strategic Positioning - Changan Automobile is establishing a new subsidiary, Changan Tian Shu Intelligent Robot Technology Co., Ltd., marking its entry into the robotics industry as a state-owned enterprise [2] - The establishment aligns with China's 14th Five-Year Plan and Changan's strategic transformation, aiming to create innovative "embodied intelligence" products and solutions [2] - The company aims to become a world-class provider of robotic products and services, facilitating the dual empowerment of the automotive and robotics industries [2] Group 2: Talent and Technology Reserves - Dr. Tan Huan, Chief Intelligent Robot System Architect, has extensive experience and accolades in robotics, including awards from IEEE and the Edison Award [2] - Changan has developed its first humanoid robot, "Xiao An," which was showcased at the Guangzhou International Auto Show, with plans to release prototypes next year [2] Group 3: Strategic Layout and Business Planning - The robotics strategy is structured around a "1+N+X" model, focusing on humanoid robots while integrating various applications such as vehicle-mounted robots and smart mobility robots [3] - The company plans to leverage its existing intelligent driving technology to enhance its robotics capabilities and integrate core technologies with industry partners [3] Group 4: Competitive Advantages - Policy Advantage: Changan's robotics initiative aligns with national policies, allowing it to secure support and funding as a leading state-owned enterprise in this sector [3] - Technological Edge: The company’s robotics platform is positioned at the forefront of the industry, capable of matching and exceeding the functionalities of competitors' robots [3] - Application Scenarios: Changan is advancing in integrating automotive and robotics technologies, establishing a competitive edge in innovative applications [3] - Ecosystem Integration: The company utilizes its position in the automotive supply chain to comprehensively develop hardware, software, and services [3] - Product Launch Advantage: Changan's experience in navigating regulatory approvals for vehicle-mounted robots provides a head start in product deployment [3]
国机精工(002046) - 002046国机精工投资者关系管理信息20251128
2025-12-01 01:08
国机精工集团股份有限公司投资者关系活动记录表 编号:2025—028 | | ☑ 特定对象调研 □分析师会议 | | --- | --- | | 投资者关系 | □媒体采访 □业绩说明会 | | 活动类别 | □新闻发布会 □路演活动 | | | □现场参观 □电话会议 | | | □其他 | | 参与单位名称 | 渤海证券 宁前羽 | | 及人员姓名 | | | 时间 | 2025 年 11 月 28 日 | | 地点 | 国机精工 会议室 | | 上市公司接待 | 董事会秘书:赵祥功 | | 人员姓名 | 投资者关系助理:汪智婷 | | | 1.问:请简单介绍一下公司的主营业务。 | | | 答:国机精工在轴承行业和磨料磨具行业开展业务,提供满足国 | | | 家战略需求的产品、技术和服务,业务涵盖"新材料、基础零部件、 | | | 机床工具、高端装备、供应链管理与服务"五大业务板块。总体来看, | | | 目前,特种轴承以及超硬材料磨具业务是公司利润的主要来源,风电 | | | 轴承是增速最快的业务。 | | | 公司轴承业务的核心支撑力量为洛阳轴承研究所有限公司、超硬 | | | 材料及制品的核心支撑 ...
湖南裕能(301358) - 2025年11月28日投资者关系活动记录表
2025-12-01 01:06
证券代码:301358 证券简称:湖南裕能 | | □特定对象调研 □分析师会议 | | | --- | --- | --- | | 投资者关系活 | □媒体采访 □业绩说明会 | | | | □新闻发布会 □路演活动 | | | 动类别 | □现场参观 | | | | ☑ 其他(电话会议) | | | | 交银施罗德基金、贝莱德、兴全基金、财通基金、国海证券、花旗 | | | 参与单位名称 | 环球 | | | 时间 | 2025 年 11 月 日 | 28 | | 地点 | 电话会议 | | | 上市公司接待 | 董事、副总经理兼董事会秘书 汪咏梅 | | | 人员姓名 | 证券事务代表 何美萱 | | | | 1、近期行业协会召开了会议并推出行业成本指数,请问后续将 | | | | 采取什么措施? | | | | 回复:近期,中国化学与物理电源行业协会铁锂材料分会发布 | | | | 了磷酸铁锂材料成本指数,并倡议将其作为企业报价的重要参考依 | | | | 据,旨在遏制行业"内卷式"恶性竞争,推动行业从"规模竞争" | | | 投资者关系活 | 向"质量竞争"跨越。公司将与行业各方共同维护健康有序的市 ...
达 意 隆(002209) - 2025年11月28日投资者关系活动记录表
2025-12-01 00:32
证券代码:002209 证券简称:达意隆 | 场增速明显,市场规模将持续增长。随着城市化率提升和居 | | --- | | 民收入增加,消费结构也会发生变化,饮料产品亦将呈现多 | | 元化发展趋势,未来增量空间确定性高。 | | 3、随着国际订单的增加,公司的销售费用是否也会持续增 | | 加?公司对于相关费用是否会进行积极控制? | | 答:根据公司《2025年第三季度报告》的数据显示,公司在 | | 销售费用率、管理费用率和财务费用率上均低于行业均值, | | 处于行业合理区间。未来,公司将会通过积极有效的成本管 | | 理,确保期间费用的增长得到有效控制。 | | 4、目前境外市场毛利率比国内高的原因是什么? | | 答:公司境外市场毛利率高于国内,主要得益于产品性价比 | | 优势、市场竞争格局差异及产品结构优化等因素。 | | 5、目前公司在手订单及产能利用率的情况? | | 答:目前公司在手订单较为充足,正通过合理排产及供应链 | | 协同等方式有序生产。 | | 6、客户下单之后,订单转化成收入的周期大概是多久? | | 答:公司业务模式兼具机械制造和工程施工的特征,销售收 | | 入确认及成 ...
伊戈尔(002922) - 002922伊戈尔投资者关系管理信息20251130
2025-11-30 15:18
Group 1: Company Overview and Operations - Igor Electric Co. has established overseas factories with significant production capacities, including a Thai factory capable of producing 700 units of new energy transformers per month and a Mexican factory expected to reach a capacity of 500 units per month by mid-next year [3] - The company is expanding its product offerings in the data center sector, including phase-shifting transformers, dry-type transformers, and oil-immersed transformers, with sales extending to markets such as Japan, the USA, and Malaysia [4] Group 2: Market Expansion and Client Engagement - Igor Electric has formed partnerships with leading North American clients for EPC cooperation, driven by the increasing demand for transformers in the renewable energy sector [3] - The company aims to enhance its brand recognition and support overseas business expansion through its planned H-share listing, with funds allocated for R&D, production facility development, and global manufacturing layout [5] Group 3: Future Goals and Strategic Focus - The company is focused on building and releasing domestic and international production capacities, enriching its product matrix, and enhancing product competitiveness [6] - Igor Electric plans to continue investing in the data center power equipment sector, leveraging its digital manufacturing advantages to create reliable and energy-efficient solutions [4]
安科生物(300009) - 300009安科生物投资者关系管理信息20251130
2025-11-30 15:14
Group 1: Company Overview and Leadership - Anke Bioengineering has strategic partnerships with companies like Boshengji, Afana, and Yuansong Bio, focusing on innovative drug development and commercialization [3][4][5][6] - The leadership team includes Chairman and President Song Lihua, Vice Chairman Zhou Yuanyuan, and several vice presidents overseeing various departments [2][3] Group 2: Research and Development Highlights - Boshengji's CAR-T PA3-17 has entered critical clinical trial phases, aiming for full patient enrollment by Q1 2027 and pre-NDA communication submission [3] - Yuansong Bio's lead product, recombinant L-IFN adenovirus injection, has progressed to Phase IIa clinical trials in China [5] - Afana has received clinical trial approvals for six Class I new drugs, focusing on autoimmune diseases and mRNA therapies, with significant advancements in CAR-T and HPV treatments [6][7] Group 3: Product Pipeline and Market Strategy - The company is advancing a long-acting growth hormone, expected to be approved by the end of 2025, with a focus on leveraging its commercial capabilities [4][8] - The long-acting follicle-stimulating hormone has begun market entry, with ongoing efforts to establish partnerships with private hospitals for sales [9] - The dual-target Her2 and PD-L1*4-1BB antibodies are in clinical development, with plans for IND submission in 2027 [10][11] Group 4: Financial and Market Positioning - The company aims to maintain stable growth in its traditional business while expanding into innovative drug markets [11] - Strategic focus on optimizing product structure and enhancing market competitiveness through accelerated commercialization and R&D capabilities [11] - The company is developing a comprehensive 3, 5, and 10-year strategic plan to address market challenges and enhance its positioning in the capital market [11]
东方精工(002611) - 投资者关系活动记录表(2025年11月30日)
2025-11-30 13:16
Group 1: Strategic Focus and Asset Sale - The company aims to optimize resource allocation and focus on domestic development of technology and new productivity businesses by selling certain assets, with a strategic shift towards emerging industries [2][4][7]. - The asset sale is part of the company's commitment to the national "new productivity" strategy and technology transformation, with a focus on high-end intelligent equipment manufacturing [3][5][7]. - The base consideration for the asset sale is €774 million, which will be prudently managed to support the implementation of the technology transformation strategy [8]. Group 2: Business Development and Investment - The company plans to increase investment in its water propulsion equipment business, particularly in the subsidiary Baisheng Power, which has seen a compound annual growth rate (CAGR) of over 20% in revenue and net profit over the past five years [9][10]. - Baisheng Power is positioned to become a world-class supplier of water propulsion equipment, with a focus on developing high-horsepower outboard engines [11]. - The company has made strategic investments in artificial intelligence and robotics, as well as controllable nuclear fusion, to align with national development strategies and explore new growth areas [12][13][15]. Group 3: Market Position and Future Outlook - The global market for outboard engines exceeds $100 billion, with leading brands like Yamaha and Mercury generating significant revenues, highlighting the growth potential for Baisheng Power [10]. - The new manufacturing base in Suzhou is expected to enhance production capacity and support the launch of advanced products, contributing to future sales growth [11]. - The company is committed to enhancing shareholder returns, having distributed over ¥2.1 billion in dividends and share buybacks since its listing [8].